Demonstration of Bioequivalence of Empagliflozin and Metformin Given in One Tablet Compared to the Intake of Single Tablets

NCT01672788 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Empagliflozin
DRUG: Empagliflozin + Metformin
DRUG: Metformin
DRUG: Metformin
DRUG: Empagliflozin + Metformin
DRUG: Empagliflozin

Sponsor

Boehringer Ingelheim